ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Probiotic Improved Mens Fertility LH FSH Testosterone
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Robotics" data-source="post: 172127" data-attributes="member: 38164"><p><span style="font-size: 22px"><strong>Summary</strong></span></p><p>The hypothesis that the assumption of a probiotic associated with a prebiotic (Flortec, Bracco; one sachet contains: <em>Lactobacillus paracasei</em> B21060 5 × 109 cells + arabinogalctan 1243 mg + oligo‐fructosaccharides 700 mg + l‐glutamine 500 mg) could improve the quality and quantity of spermatozoa in idiopathic oligoasthenoteratospermia (iAOT) patients to a larger extent than a control substance (starch) was tested. Forty‐one patients with no chromosomal aberrations were randomized into two groups: 20 received Flortec, one sachet per day for 6 months, whereas 21 received the control substance. The following data were collected: clinical history, scrotal Doppler scans, Y microdeletion, karyotype and cystic fibrosis screens, follicle‐stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), testosterone (T), and prolactin (PRL) levels, and two semen analyses. Both the Flortec and the starch groups underwent two semen analyses and one FSH, LH, T, E2, and PRL measurement in the blood, at the beginning of the study, and after 6 months. The comparisons were carried out using a non‐parametric (Wilcoxon signed rank) test. The side effects were assessed and compared using the chi‐squared test. Group 1 (Flortec) had their sperm count improved: volume of the ejaculate (median from 2.4 to 3.1 mL; <em>p</em> < 0.01), sperm concentration (median: from 15.2 × 106/mL to 28.3 × 106/39 mL; <em>p</em> < 0.01), progressive motility (median: from 16.2 to 42.0%; <em>p</em> < 0.01), and the percentage of typical forms (median: from 7 to 16.3%; <em>p</em> < 0.01); in addition, their FSH, LH, and T levels improved (<em>p</em> < 0.01), while those of E2 and PRL did not. Group 2 (control substance) had no modification in 42 of the parameters studied. There were no side effects in either group. These data showed that Flortec constitutes a safe therapy for improving the volume of the ejaculate and the quality/quantity of spermatozoa in iOAT patients.</p><p></p><p>[ATTACH=full]9264[/ATTACH]</p><p></p><p>Link to full paper below</p><p></p><p><a href="https://rdcu.be/b1Vnw" target="_blank">Full Paper Text</a></p></blockquote><p></p>
[QUOTE="Robotics, post: 172127, member: 38164"] [SIZE=22px][B]Summary[/B][/SIZE] The hypothesis that the assumption of a probiotic associated with a prebiotic (Flortec, Bracco; one sachet contains: [I]Lactobacillus paracasei[/I] B21060 5 × 109 cells + arabinogalctan 1243 mg + oligo‐fructosaccharides 700 mg + l‐glutamine 500 mg) could improve the quality and quantity of spermatozoa in idiopathic oligoasthenoteratospermia (iAOT) patients to a larger extent than a control substance (starch) was tested. Forty‐one patients with no chromosomal aberrations were randomized into two groups: 20 received Flortec, one sachet per day for 6 months, whereas 21 received the control substance. The following data were collected: clinical history, scrotal Doppler scans, Y microdeletion, karyotype and cystic fibrosis screens, follicle‐stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), testosterone (T), and prolactin (PRL) levels, and two semen analyses. Both the Flortec and the starch groups underwent two semen analyses and one FSH, LH, T, E2, and PRL measurement in the blood, at the beginning of the study, and after 6 months. The comparisons were carried out using a non‐parametric (Wilcoxon signed rank) test. The side effects were assessed and compared using the chi‐squared test. Group 1 (Flortec) had their sperm count improved: volume of the ejaculate (median from 2.4 to 3.1 mL; [I]p[/I] < 0.01), sperm concentration (median: from 15.2 × 106/mL to 28.3 × 106/39 mL; [I]p[/I] < 0.01), progressive motility (median: from 16.2 to 42.0%; [I]p[/I] < 0.01), and the percentage of typical forms (median: from 7 to 16.3%; [I]p[/I] < 0.01); in addition, their FSH, LH, and T levels improved ([I]p[/I] < 0.01), while those of E2 and PRL did not. Group 2 (control substance) had no modification in 42 of the parameters studied. There were no side effects in either group. These data showed that Flortec constitutes a safe therapy for improving the volume of the ejaculate and the quality/quantity of spermatozoa in iOAT patients. [ATTACH=full]9264[/ATTACH] Link to full paper below [URL='https://rdcu.be/b1Vnw']Full Paper Text[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Probiotic Improved Mens Fertility LH FSH Testosterone
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top